Stephen L. Huhn - CMO & Sr VP, Clinical Dev. at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CMO & Sr VP, Clinical Dev.
Issuer Symbol
CTNM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen L. Huhn since 12 Mar 2025

Holdings reported by Stephen L. Huhn for Contineum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 12,800 $218,240 $17.05 13 Aug 2024 Direct
Stock Option (right to buy) 110,000 31 Jan 2025 Direct Class A Common Stock

Transactions reported by Stephen L. Huhn for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.